Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion type Assertion NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_head.
- NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion description "[The diagnosis of therapy-related myeloid leukemia (t-MDS/t-AML) identifies a group of high-risk patients with multiple and varied poor prognostic features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_provenance.
- NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion evidence source_evidence_literature NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_provenance.
- NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion SIO_000772 18024664 NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_provenance.
- NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion wasDerivedFrom befree-20140225 NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_provenance.
- NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_assertion wasGeneratedBy ECO_0000203 NP542663.RAKGc8qg2myoN1Vxan9HQPYwxSWls76kCBUM2NL3RM4-s130_provenance.